These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17361343)

  • 21. Combined magnetic resonance imaging and single-photon emission tomography scanning in the discrimination of Alzheimer's disease from age-matched controls.
    O'Brien JT; Ames D; Desmond P; Lichtenstein M; Binns D; Schweitzer I; Davis S; Tress B
    Int Psychogeriatr; 2001 Jun; 13(2):149-61. PubMed ID: 11495391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen therapy and brain muscarinic receptor density in healthy females: a SPET study.
    Norbury R; Travis MJ; Erlandsson K; Waddington W; Ell PJ; Murphy DG
    Horm Behav; 2007 Feb; 51(2):249-57. PubMed ID: 17173920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique.
    Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Yoshioka S; Sato M; Fukuda H
    J Nucl Med; 1999 Feb; 40(2):244-9. PubMed ID: 10025830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic simulations of SPECT quantitation of the M2 muscarinic neuroreceptor subtype in disease states using radioiodinated (R,R)-4IQNB.
    Zeeberg BR; Kim HJ; Reba RC
    Life Sci; 1992; 51(9):661-70. PubMed ID: 1501511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations of muscarinic acetylcholine receptor subtypes in diffuse lewy body disease: relation to Alzheimer's disease.
    Shiozaki K; Iseki E; Uchiyama H; Watanabe Y; Haga T; Kameyama K; Ikeda T; Yamamoto T; Kosaka K
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):209-13. PubMed ID: 10406992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoradiographic evidence that 3-quinuclidinyl-4-fluorobenzilate (FQNB) displays in vivo selectivity for the m2 subtype.
    Boulay SF; Sood VK; Rayeq MR; Cohen VI; Zeeberg BR; Reba RC
    Neuroimage; 1996 Feb; 3(1):35-9. PubMed ID: 9345473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo m2 muscarinic subtype selectivity of some dibenzodiazepinones and pyridobenzodiazepinones.
    Cohen VI; Jin B; McRee RC; Boulay SF; Cohen EI; Sood VK; Zeeberg BR; Reba RC
    Brain Res; 2000 Apr; 861(2):305-15. PubMed ID: 10760492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.
    Colloby SJ; Firbank MJ; Pakrasi S; Lloyd JJ; Driver I; McKeith IG; Williams ED; O'Brien JT
    Int Psychogeriatr; 2008 Dec; 20(6):1124-40. PubMed ID: 18752700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscarinic cholinergic receptor binding: in vivo depiction using single photon emission computed tomography and radioiodinated quinuclidinyl benzilate.
    Drayer B; Jaszczak R; Coleman E; Storni A; Greer K; Petry N; Lischko M; Flanagan S
    J Comput Assist Tomogr; 1982 Jun; 6(3):536-43. PubMed ID: 6980235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Memory-provoked rCBF-SPECT as a diagnostic tool in Alzheimer's disease?
    Sundström T; Elgh E; Larsson A; Näsman B; Nyberg L; Riklund KA
    Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):73-80. PubMed ID: 16151770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative analysis of brain perfusion SPECT in Alzheimer's disease using a fully automated regional cerebral blood flow quantification software, 3DSRT.
    Kobayashi S; Tateno M; Utsumi K; Takahashi A; Saitoh M; Morii H; Fujii K; Teraoka M
    J Neurol Sci; 2008 Jan; 264(1-2):27-33. PubMed ID: 17764699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: a SPECT blood flow study.
    Brown DR; Hunter R; Wyper DJ; Patterson J; Kelly RC; Montaldi D; McCullouch J
    J Psychiatr Res; 1996; 30(2):109-26. PubMed ID: 8816305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholinergic and perfusion brain networks in Parkinson disease dementia.
    Colloby SJ; McKeith IG; Burn DJ; Wyper DJ; O'Brien JT; Taylor JP
    Neurology; 2016 Jul; 87(2):178-85. PubMed ID: 27306636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks.
    Varrone A; Pappatà S; Caracò C; Soricelli A; Milan G; Quarantelli M; Alfano B; Postiglione A; Salvatore M
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1447-54. PubMed ID: 12397463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoradiographic evidence that quinuclidinyl 4-(bromophenyl)-2-thienylglycolate (QBPTG) displays in vivo selectivity for the muscarinic m2 subtype.
    Boulay SF; Sood VK; Rayeq MR; McRee RC; Cohen EI; Cohen VI; Zeeberg BR; Reba RC
    Neuroimage; 1995 Sep; 2(3):209-13. PubMed ID: 9343604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the in vivo rat brain regional pharmacokinetics of [3H]QNB, (R,S)-[125I]-4IQNB, and (R,R)-[125I]-4IQNB binding to the muscarinic acetylcholine receptor in relationship to the regional subtype composition.
    Boulay SF; Gitler MS; Sood VK; Cohen VI; Zeeberg BR; Reba RC
    Receptor; 1995; 5(4):207-18. PubMed ID: 8840399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spatial Covariance of Cholinergic Muscarinic M
    Colloby SJ; Nathan PJ; Bakker G; Lawson RA; Yarnall AJ; Burn DJ; O'Brien JT; Taylor JP
    Mov Disord; 2021 Aug; 36(8):1879-1888. PubMed ID: 33973693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The distribution of cerebral muscarinic acetylcholine receptors in vivo in patients with dementia. A controlled study with 123IQNB and single photon emission computed tomography.
    Weinberger DR; Gibson R; Coppola R; Jones DW; Molchan S; Sunderland T; Berman KF; Reba RC
    Arch Neurol; 1991 Feb; 48(2):169-76. PubMed ID: 1993008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F; Brugnolo A; Calvini P; Copello F; De Leo C; Girtler N; Morbelli S; Piccardo A; Vitali P; Rodriguez G
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of stereoisomers of 4-fluoroalkyl analogues of 3-quinuclidinyl benzilate in in vivo competition studies for the M1, M2, and M3 muscarinic receptor subtypes in brain.
    Lee J; Paik CH; Kiesewetter DO; Park SG; Eckelman WC
    Nucl Med Biol; 1995 Aug; 22(6):773-81. PubMed ID: 8535338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.